Earendil

Every AIbrief event involving Earendil, in order.

1. August 5, 2026 · Funding · 1 source

   Earendil faces regulatory scrutiny during Hong Kong IPO process

   The Wall Street Journal reports that Earendil, a Chinese AI biotechnology company, has encountered a regulatory hurdle as it pursues a Hong Kong initial public offering. According to the report, Chinese regulators raised concerns about the company's red-chip holding structure after it recently submitted its IPO application.